SaNOtize
Signal active
Organization
Contact Information
Overview
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections. The company develops a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial infections, including drug resistant microbes. Its target indications include treatment for strep throat, athlete's foot, infected wounds, diabetic foot ulcers, sinusitis, cold and flu, and others.
SaNOtize was founded in 2017 by Gilly Regev and Chris Miller and it is headquartered in Vancouver, British Columbia.
About
Industries
Biotechnology, Life Science, Medical
Founded
2017
Employees
11-50
Headquarters locations
North America
Social
N/A
Profile Resume
SaNOtize headquartered in North America, operates in the Biotechnology, Life Science, Medical sector. The company focuses on Biotechnology and has secured $954.0M in funding across 36 round(s). With a team of 11-50 employees, SaNOtize is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - SaNOtize, raised $24.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
3
Lead Investors
0
Total Funding Amount
$26.5M
Details
3
SaNOtize has raised a total of $26.5M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 2.5M | ||
| 2018 | Seed | |||
| 2022 | Early Stage Venture | 24.0M |
Investors
SaNOtize is funded by 13 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Agricultural Bank of China | - | FUNDING ROUND - Agricultural Bank of China | 24.0M |
| Jonathan Medved | - | FUNDING ROUND - Jonathan Medved | 24.0M |
| SaNOtize | - | FUNDING ROUND - SaNOtize | 24.0M |
| OurCrowd | - | FUNDING ROUND - OurCrowd | 24.0M |
Recent Activity
There is no recent news or activity for this profile.